Steri-Pharma buys underperformer; Watch Tamiflu dosing;

> Sterile antibiotic maker Steri-Pharma has bought and will continue operating a cephalosporin manufacturing plant from Hanford Pharmaceuticals, which said the plant was underperforming. Article

> The Food and Drug Administration is asking doctors and pharmacists to look for dosing errors with oral Tamiflu. Article

> Drug developer and CMO Patheon has opened a pharmaceutical development services manufacturing site for investigational products within its existing manufacturing facility in Ferentino, Italy. Release

> Nycomed says it will spend about $100 million on a plant in Yaroslavl, Russia, several hundred kilometers from Moscow, to manufacture active pharmaceutical ingredients and finished dosage forms for Russia and surrounding markets. Article

> American Airlines Cargo Division (AA Cargo) has begun offering an ExpediteTC express temperature-controlled service to customers worldwide, following a trial in the early summer between ten US and international cities. Item

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.